Negative regulation of osteoblastogenesis through downregulation of runt-related transcription factor-2 in osteoblastic MC3T3-E1 cells with stable overexpression of the cystine/glutamate antiporter xCT subunit

Journal of Cellular Physiology

Volumn 226, Issue 11, 2011, Pages 2953-2964

  Uno, Kyosuke ^a   Takarada, Takeshi ^a   Takarada Iemata, Mika ^a   Nakamura, Yukari ^a   Fujita, Hiroyuki ^a   Hinoi, Eiichi ^a   Yoneda, Yukio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIPORTER; CYSTINE; GLUTAMIC ACID; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL STRAIN; CULTURE MEDIUM; DOWN REGULATION; EXPRESSION VECTOR; GENE OVEREXPRESSION; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOBLASTOGENESIS; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; CALCIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION; GLUTATHIONE; MICE; OSTEOBLASTS; OSTEOGENESIS; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; TETRAZOLIUM SALTS; THIAZOLES;

MURINAE;

EID: 80051948349     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22642     Document Type: Article

References (40)

1. Alisi A, Piemonte F, Pastore A, Panera N, Passarelli C, Tozzi G, Petrini S, Pietrobattista A, Bottazzo GF, Nobili V. 2009. Glutathionylation of p65NF-kappaB correlated with proliferating/apoptotic hepatoma cells exposed to pro-and anti-oxidants. Int J Mol Med 24: 319-326.
2. Bannai S, Takada A, Kasuga H, Tateishi N. 1986. Induction of cystine transport activity in isolated rat hepatocytes by sulfobromophthalein and other electrophilic agents. Hepatol 6: 1361-1368.
3. Cho Y, Bannai S. 1990. Uptake of glutamate and cystine in C-6 glioma cells and cultured astrocyte. J Neurochem 55: 2091-2097.
4. D'Amico M, Wu K, Fu M, Rao M, Albanese C, Russell RG, Lian H, Bregman D, White MA, Pestell RG. 2004. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements. Cancer Res 64: 4122-4130.
5. Dringen R. 2000. Metabolism and functions of glutathione in brain. Prog Neurobiol 62: 649-671.
6. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
7. Fratelli M, Goodwin LO, Orom UA, Lombardi S, Tonelli R, Mengozzi M, Ghezzi P. 2005. Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proc Natl Acad Sci USA 102: 13998-14003.
8. 2+ influx through acquired and native N-methyl-D-aspartate receptor channels. J Pharmacol Sci 112: 273-281.
9. Galindo M, Kahler RA, Teplyuk NM, Stein JL, Lian JB, Stein GS, Westendorf JJ, van Wijnen AJ. 2007. Cell cycle related modulations in Runx2 protein levels are independent of lymphocyte enhancer-binding factor 1 (Lef1) in proliferating osteoblasts. J Mol Histol 38: 501-506.
10. Hayes JD, McMahon M. 2009. NRF2 and KEAP1 mutations: Permanent activation of an adaptive response in cancer. Trends Biochem Sci 34: 176-188.
11. Hinoi E, Fujimori S, Yoneda Y. 2003. Modulation of cellular differentiation by N-methyl-D-aspartate receptors in osteoblasts. FASEB J 17: 1532-1534.
12. Inada M, Yasui T, Nomura S, Miyake S, Deguchi K, Himeno M, Sato M, Yamagiwa H, Kimura T, Yasui N, Ochi T, Endo N, Kitamura Y, Kishimoto T, Komori T. 1999. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 214: 279-290.
13. Kaneki H, Guo R, Chen D, Yao Z, Schwarz EM, Zhang YE, Boyce BF, Xing L. 2006. Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. J Biol Chem 281: 4326-4333.
14. Kim IS, Otto F, Zabel B, Mundlos S. 1999. Regulation of chondrocyte differentiation by Cbfa1. Mech Dev 80: 159-170.
15. Kobayashi T, Kronenberg H. 2005. Minireview: Transcriptional regulation in development of bone. Endocrinology 146: 1012-1017.
16. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
17. Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ. 2003. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112: 915-923.
18. Lee JS, Surh YJ. 2005. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett 224: 171-184.
19. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
20. Motohashi H, Yamamoto M. 2004. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10: 549-557.
21. Murphy TH, Schnaar RL, Coyle JT. 1990. Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J 4: 1624-1643.
22. Nakamura Y, Takarada T, Kodama A, Hinoi E, Yoneda Y. 2009. Predominant promotion by tacrolimus of chondrogenic differentiation to proliferating chondrocytes. J Pharmacol Sci 109: 413-423.
23. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblastic differentiation and bone formation. Cell 108: 17-29.
24. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771.
25. Pacheco R, Oliva H, Martinez-Navio JM, Climent N, Ciruela F, Gatell JM, Gallart T, Mallol J, Lluis C, Franco R. 2006. Glutamate released by dendritic cells as a novel modulator of T cell activation. J Immunol 177: 6695-6704.
26. Sasaki H, Sato H, Kuriyama-Matsumura K, Sato K, Maebara K, Wang H, Tamba M, Itoh K, Yamamoto M, Bannai S. 2002. Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem 277: 44765-44771.
27. Sato H, Fujiwara K, Sagara J, Bannai S. 1995. Induction of cystine transport activity in mouse peritoneal macrophages by bacterial lipopolysaccharide. Biochem J 310: 547-551.
28. Sato H, Shiiya A, Kimata M, Maebara K, Tamba M, Sakakura Y, Makino N, Sugiyama F, Yagami K, Moriguchi T, Takahashi S, Bannai S. 2005. Redox imbalance in cystine/glutamate transporter-deficient mice. J Biol Chem 280: 37423-37429.
29. Schulz JB, Lindenau J, Seyfried J, Dichgans J. 2000. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267: 4904-4911.
30. Shen R, Wang X, Drissi H, Liu F, O'Keefe RJ, Chen D. 2006. Cyclin D1-cdk4 induce runx2 ubiquitination and degradation. J Biol Chem 281: 16347-16353.
31. Shih AY, Erb H, Sun X, Toda S, Kalivas PW, Murphy TH. 2006. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci 26: 10514-10523.
32. Takarada T, Hinoi E, Fujimori S, Tsuchihashi Y, Ueshima T, Taniura H, Yoneda Y. 2004. Accumulation of [3H] glutamate in cultured rat calvarial osteoblasts. Biochem Pharmacol 68: 177-84.
33. Takarada T, Hinoi E, Kambe Y, Sahara K, Kurokawa S, Takahata Y, Yoneda Y. 2007. Osteoblast protects osteoclast devoid of sodium-dependent vitamin C transporters from oxidative cytotoxicity of ascorbic acid. Eur J Pharmacol 575: 1-11.
34. Takeda S, Bonnamy JP, Owen MJ, Ducy P, Karsenty G. 2001. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev 15: 467-481.
35. Trost Z, Trebse R, Prezelj J, Komadina R, Logar DB, Marc J. 2010. A microarray based identification of osteoporosis-related genes in primary culture of human osteoblasts. Bone 46: 72-80.
36. Uno K, Takarada T, Hinoi E, Yoneda Y. 2007. Glutamate is a determinant of cellular proliferation through modulation of nuclear factor E2 p45-related factor-2 expression in osteoblastic MC3T3-E1 cells. J Cell Physiol 213: 105-114.
37. Wang L, Hinoi E, Takemori A, Nakamichi N, Yoneda Y. 2006. Glutamate inhibits chondral mineralization through apoptotic cell death mediated by retrograde operation of the cystine/glutamate antiporter. J Biol Chem 281: 24553-24565.
38. Xie Y, Kole S, Precht P, Pazin MJ, Bernier M. 2009. S-glutathionylation impairs signal transducer and ativator of transcription 3 activation and signaling. Endocrinol 150: 1122-1131.
39. Zambotti A, Makhluf H, Shen J, Ducy P. 2002. Characterization of an osteoblast-specific enhancer element in the CBFA1 gene. J Biol Chem 277: 41497-44506.
40. Zhang Y, Gordon GB. 2004. A strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway. Mol Cancer Ther 3: 885-893.